EU efforts to show solidarity in the face of the coronavirus pandemic have suffered a setback after Hungary decided to go ahead and authorize the use of the Oxford/AstraZeneca vaccine outside the ongoing EU centralized approval procedure.
The Hungarian National Institute of Pharmacy and Nutrition (OGYEI) said it had issued an emergency use authorization (EUA) for the vaccine, even though the European Medicines Agency is expected to make a recommendation on
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?